The conference that has opened this morning the contest has been in charge of the Catalan doctor who directs Área Oftalmológica Avanzada, a pioneering clinic in Europe in the treatment of Dry Eye.
London, March 15 of 2017. Under the title Intence ultra-regulated pulsed light in the treatmnet of Meibomian Gland Dysfunction, The doctor. Carlos Vergés He has given this conference that has addressed the dysfunction treatments of Meibomian glandscausing Dry Eye.
It was the conference that opened the 9 edition of the International Ophthalmological Congress that brings together the European medical community until tomorrow en London. The appointment has been used by Dr. Carlos Vergés to present the first specific laser to combat dry eye, a worldwide discovery that has been patented in Barcelona by AOA, the clinic that he directs.
The patent of dr. Vergés, ThermaEye, is based on the Pulsed light High intensity, a technology from the dermatology and tissue regeneration sector. Is the first laser treatment that has an ophthalmological certificate, professional recognition that postulates it as the best and most appropriate of the current treatments against Dry Eye. In fact, its revolutionary technology allows to treat other eye diseases and Blepharitis (inflammation of the Eyelids), The conjunctivitis and infection by Demodex (dust mite that colonizes the glands of the eyelids).
ThermaEye uses LIUR technology (Intense Ultra-Regulated Light) instead of high intensity pulsed light, as is the case with traditional IPL equipment used in dermo-aesthetics. This advanced technology is applied to the patient in a constant series of low-intensity micropulses, which allow natural cooling of the skin and prevents harmful side effects. With ThermaEye, the treatment can be performed directly on any type of skin (from phototype 1 to 6) without having to use filters or other additional cooling systems, necessary in laser and IPL laser platforms to avoid burns or changes in skin pigmentation.
